Cadrenal TherapeuticsCVKD
13F holders, Q1 2024 (March 31)10holders
2famous investors
$0.61avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Cadrenal Therapeutics Inc. (CVKD) in their 13F filings. The largest holders were Armistice Capital, LLC ($823K), Renaissance Technologies ($90K) and Citadel Advisors ($34K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cadrenal Therapeutics Inc.
- CUSIP
- 127636108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $83K |
| Exits | 0 | $0 |
Ownership 10 holders
| Armistice Capital, LLC | 0.02% | Add +225.8% | 1,349,586 | $823K |
| Renaissance Technologies | 0.00% | Add +87.3% | 148,138 | $90K |
| Citadel Advisors | 0.00% | New | 55,848 | $34K |
| Geode Capital Management, LLC | 0.00% | Add +10.6% | 42,865 | $26K |
| Virtu Financial LLC | 0.00% | New | 32,380 | $20K |
| Avantax Planning Partners, Inc. | 0.00% | New | 28,305 | $17K |
| XTX Topco Ltd | 0.00% | New | 19,738 | $12K |
| Biltmore Family Office, LLC | 0.00% | No change | 11,000 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +12.1% | 9,520 | $6K |
| Wells Fargo & Company | 0.00% | Add +1.9% | 54 | $33 |
"% of holder's portfolio" is CVKD's weight in each manager's 13F, not the share of Cadrenal Therapeutics Inc. the manager owns.